Zhuoer Xie

33PUBLICATIONS
230CO-AUTHORS
Regenerative medicine (incl. stem cells)Haematological tumoursGene and molecular therapyMedical molecular engineering of nucleic acids and proteinsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (33)

|Aug 27, 2026
Impact of Response to Hypomethylating Agent-Based Therapy on Survival Outcomes in the Context of Baseline Clinical-Molecular Risk and Transplant Status in Patients With Higher-Risk Myelodysplastic Syndromes/Neoplasms: An analysis From the International Consortium for MDS (icMDS).

|Jul 29, 2026
Clinical and Genomic Convergence of High-Risk CCUS and Lower-Risk Myelodysplastic Syndromes/Neoplasms.

|Jun 29, 2026
Outcomes of patients with higher-risk myelodysplastic syndromes/neoplasms treated with hypomethylating agents + venetoclax-an analysis from the International Consortium for MDS (icMDS) VALIDATE database.

|Feb 16, 2026
Modeling the evolutionary dynamics of clonal hematopoiesis.

Sadegh Marzban, Thomas Stiehl, Zhuoer Xie

|Feb 11, 2026
Prognostic Model Combining Mutational and Cytogenetic Profiles in Acute Myeloid Leukemia Treated with Venetoclax and Hypomethylating Agents.

Dimitrios Drekolias, Fatima Tuz Zahra, Caroline Fileni

|Jan 26, 2026
Baseline IPSS-M vs pretransplant risk downstaging as prognostic determinants in MDS undergoing allogeneic transplantation.

Luis E Aguirre, Haesook T Kim, Hany Elmariah

Pageof 6

Frequent Collaborators

15 joint publications

Rami S Komrokji

12 joint publications

David Sallman

12 joint publications

Mrinal Patnaik

8 joint publications

Eric Padron